| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 1.38T | 1.37T | 1.35T | 1.32T | 1.28T | 1.20T |
| Gross Profit | 15.68B | 14.01B | 6.45B | -2.32B | 3.56B | 6.29B |
| EBITDA | 424.17B | 421.31B | 372.59B | 269.36B | 296.28B | 277.63B |
| Net Income | 84.35B | 85.28B | 72.14B | 4.77B | 50.29B | 49.15B |
Balance Sheet | ||||||
| Total Assets | 6.79T | 6.86T | 6.46T | 6.08T | 5.66T | 5.60T |
| Cash, Cash Equivalents and Short-Term Investments | 606.01B | 598.36B | 601.72B | 542.78B | 593.29B | 530.66B |
| Total Debt | 4.99T | 4.95T | 4.78T | 4.54T | 4.27T | 4.30T |
| Total Liabilities | 5.66T | 5.69T | 5.45T | 5.19T | 4.87T | 4.91T |
| Stockholders Equity | 983.99B | 1.03T | 874.47B | 763.64B | 675.46B | 572.68B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 94.66B | -120.69B | -18.86B | 243.39B | 81.96B |
| Operating Cash Flow | 0.00 | 112.42B | -105.54B | -9.22B | 255.09B | 86.69B |
| Investing Cash Flow | -31.47B | -32.08B | -109.47B | -32.57B | -17.40B | -92.30B |
| Financing Cash Flow | -43.38B | -42.77B | 262.87B | 8.19B | -200.10B | 13.84B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | ¥122.95B | 9.20 | ― | 2.85% | 8.02% | 4.39% | |
72 Outperform | ¥1.03T | 10.73 | ― | 3.37% | 5.24% | 69.92% | |
68 Neutral | ¥32.11B | 8.57 | ― | 4.66% | -13.01% | 9.74% | |
64 Neutral | ¥392.93B | 11.14 | ― | 3.62% | -0.03% | -42.34% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
58 Neutral | ¥43.28B | 6.79 | ― | 3.90% | 0.17% | 58.30% |